SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Wound Care

PUBLISHER: Grand View Research | PRODUCT CODE: 2152400

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2152400

Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally Invasive Surgery), By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

The global bioactive wound care market size was valued at USD 12.9 Billion in 2025 and is projected to grow from USD 13.8 billion in 2026 to USD 22.8 billion by 2033, at a CAGR of 7.4% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. Key market drivers include the increasing prevalence of chronic wounds among the aging population and those with diabetes. The market is driven by strong adoption of advanced wound management technologies, reimbursement and financing, and investments in regenerative medicine and tissue engineering.

The growing adoption of bioactive wound care products due to their ability to accelerate healing and support tissue regeneration is contributing significantly to market growth. Bioactive dressings are increasingly used in the management of chronic and acute wounds because they help maintain an optimal wound environment, promote cellular activity, and reduce the risk of infection. The growing burden of chronic wounds, particularly among elderly patients and individuals with diabetes, continues to support demand for advanced wound management solutions. According to the 11th Edition of the International Diabetes Federation (IDF) Diabetes Atlas, in 2024, over 158.3 million people aged 65-99 years were living with diabetes, representing a prevalence of 23.7% among older adults.

The increasing prevalence of diabetes is contributing to a higher incidence of diabetic foot ulcers, pressure ulcers, and other chronic wounds that often require advanced wound care interventions. In addition, rising surgical procedure volumes, increasing awareness regarding effective wound management, and growing adoption of regenerative healthcare technologies are supporting market expansion. Healthcare providers are increasingly using bioactive wound care products to improve healing outcomes, reduce complications, and shorten recovery periods. As the focus on advanced wound management and patient outcomes continues to strengthen, demand for bioactive wound care solutions is expected to increase across healthcare settings.

Bioactive Wound Care Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels, providing an analysis of the latest industry trends and opportunities in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented global bioactive wound care market report on the basis of product, application, and region.

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)

Moist Wound Care

    • Foam
    • Alginate
    • Film
    • Hydrocolloid
    • Hydrogel

Antimicrobial Wound Care

    • Silver Based
    • Non-Silver Based

Active Dressing

    • Biomaterial
    • Skin Substituents
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)

General Surgery

    • Plastic
    • Dermatological
    • Pediatric

Minimally Invasive Surgery

  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand

Latin America

    • Brazil
    • Argentina

Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-1-68038-081-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioactive Wound Care Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioactive Wound Care Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioactive Wound Care Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioactive Wound Care Market: Product Movement Analysis, USD Million, 2025 & 2033
  • 4.3. Moist Wound Care
    • 4.3.1. Moist Wound Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.1. Foam
        • 4.3.1.1.1. Foam Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Alginate
        • 4.3.1.2.1. Alginate Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.3. Film
        • 4.3.1.3.1. Film Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.4. Hydrocolloid
        • 4.3.1.4.1. Hydrocolloid Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.5. Hydrogel
        • 4.3.1.5.1. Hydrogel Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Antimicrobial Wound Care
    • 4.4.1. Antimicrobial Wound Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Silver Based
        • 4.4.1.1.1. Silver Based Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.2. Non-Silver Based
        • 4.4.1.2.1. Non-Silver Based Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Active Dressing
    • 4.5.1. Active Dressing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.1. Biomaterial
        • 4.5.1.1.1. Biomaterial Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.2. Skin Substituents
        • 4.5.1.2.1. Skin Substituents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Bioactive Wound Care Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioactive Wound Care Market: Application Movement Analysis, USD Million, 2025 & 2033
  • 5.3. General Surgery
    • 5.3.1. General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.1.1. Plastic
        • 5.3.1.1.1. Plastic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.1.2. Dermatological
        • 5.3.1.2.1. Dermatological Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.1.3. Pediatric
        • 5.3.1.3.1. Pediatric Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.1.4. Others
        • 5.3.1.4.1. Others General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Minimally Invasive Surgery
    • 5.4.1. Minimally Invasive Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Bioactive Wound Care Market: Regional Estimates & Trend Analysis

  • 6.1. Bioactive Wound Care Market Share, By Region, 2025 & 2033, USD Million
  • 6.2. North America
    • 6.2.1. North America Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Essity Health & Medical
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. 3M
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Convatec Group PLC
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Covalon Technologies Ltd
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. DermaRite Industries LLC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Hollister Incorporated
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Integra LifeSciences Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Johnson & Johnson Services, Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. Medtronic
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. Monlnlycke Health Care AB
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. Smith+Nephew
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!